CoChat

Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression

Open access
Sun, Xiulian, He, Guiqiong, Qing, Hong, Zhou, Weihui, Dobie, Frederick, Cai, Fang, Staufenbiel, Matthias, Huang, L. Eric, Song, Weihong · 2006 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.

Abstract

The molecular mechanism underlying the pathogenesis of the majority of cases of sporadic Alzheimer's disease (AD) is unknown. A history of stroke was found to be associated with development of some AD cases, especially in the presence of vascular risk factors. Reduced cerebral perfusion is a common vascular component among AD risk factors, and hypoxia is a direct consequence of hypoperfusion. Previously we showed that expression of the β-site β-amyloid precursor protein (APP) cleavage enzyme 1 (BACE1) gene BACE1 is tightly controlled at both the transcriptional and translational levels and that increased BACE1 maturation contributes to the AD pathogenesis in Down's syndrome. Here we have identified a functional hypoxia-responsive element in the BACE1 gene promoter. Hypoxia up-regulated β-secretase cleavage of APP and amyloid-β protein (Aβ) production by increasing BACE1 gene transcription and expression both in vitro and in vivo . Hypoxia treatment markedly increased Aβ deposition and neuritic plaque formation and potentiated the memory deficit in Swedish mutant APP transgenic mice. Taken together, our results clearly demonstrate that hypoxia can facilitate AD pathogenesis, and they provide a molecular mechanism linking vascular factors to AD. Our study suggests that interventions to improve cerebral perfusion may benefit AD patients.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.0606298103

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 45 references

Research works printed but not linked: 1

  1. J Olin, L Schneider, A Novit, S Luczak Cochrane Database Syst Rev, CD000359. (2001).

Cited by

See all 605

Metadata

Authors
Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., Staufenbiel, M., Huang, L. E., & Song, W.
Affiliations
  • University of British Columbia (CA)
  • Novartis (Switzerland) (CH)
  • Department of Neurosurgery, University of Utah School of Medicine, Salt Lake City, UT 84112
Venue
Proceedings of the National Academy of Sciences
Published
2006-12-05
Volume
103
Issue
49
Pages
18727-18732
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2081458774
Cited by
605
References
46
Citations by year
2026: 34 · 2025: 38 · 2024: 32 · 2023: 33 · 2022: 27 · 2021: 30 · 2020: 35 · 2019: 30 · 2018: 32 · 2017: 32 · 2016: 23 · 2015: 34 · 2014: 35 · 2013: 36 · 2012: 36
FWCI
12.59
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Michael Smith Health Research BC
  • Canadian Institutes of Health Research
  • Natural Sciences and Engineering Research Council of Canada
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
Alzheimer's disease, hypoxia, BACE1, beta-secretase, APP cleavage, amyloid-beta, hypoxia response element, gene transcription, cerebral hypoperfusion, vascular risk factors, neuritic plaques, memory impairment, APP transgenic mice, cerebral perfusion
MeSH terms
Alzheimer Disease, Animals, Hypoxia, Cell Line, Humans, Mice, Transgenic, Up-Regulation, Aspartic Acid Endopeptidases, Cell Line, Tumor, Mice, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. https://app.cochat.ai/papers/10.1073/pnas.0606298103
The paper
Sun, X., He, G., Qing, H., Zhou, W., Dobie, F., Cai, F., Staufenbiel, M., Huang, L. E., & Song, W. (2006). Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0606298103

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.